Pediatric non alcoholic fatty liver disease: more on novel treatment targets

The mainstay treatment of non alcoholic fatty liver disease (NAFLD) based on weight loss and/or lifestyle changes is most often unsuccessful at all ages, thus requiring the implementation of pharmacological strategies. Targeting insulin resistance and oxidative stress has recently proven unsatisfact...

Descripción completa

Detalles Bibliográficos
Autores principales: Vajro, Pietro, Paolella, Giulia, Poeta, Marco, Pizza, Cristina, Sangermano, Maria, Massa, Grazia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3723439/
https://www.ncbi.nlm.nih.gov/pubmed/23870449
http://dx.doi.org/10.1186/1471-2431-13-109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3723439/
https://www.ncbi.nlm.nih.gov/pubmed/23870449
http://dx.doi.org/10.1186/1471-2431-13-109

Ejemplares similares